Gastric perforation in neonates: analysis of five cases.
The aetiology of neonatal gastric perforation (NGP) remains unknown and the mortality rate is still very high. We have treated five cases of gastric perforation over the past 17 years, and analysed them retrospectively to present our experience. Clinical data included age, sex, weight, maternal complication, fetal complication, gestational age, type of delivery, admission time, associated pathologies, localization of perforation, perforation age, operative procedures and outcome. There were four boys and one girl. Three of the infants were full-term, while two were premature. All of the infants were septic prior to rupture. Two infants had acute respiratory distress syndrome (ARDS); one due to prematurity and low gestational weight, and one due to meconium aspiration. Perforation was located at major curvature and anterior wall of the stomach in four patients, while it was located in minor curvature and anterior wall in one. The rupture was closed in two layers. Histopathology revealed local chronic inflammation and ischemia. Mortality rate was 60%. In conclusions, gastric perforation is a life-threatening complication in neonates. In our limited series, sepsis, prematurity and corticosteroid treatment were likely to be predictive for development of NGP. Early diagnosis and prompt management before clinical deterioration of the metabolic status may improve the outcome of such infants with NGP.
Oztürk
Hayrettin
H
Dicle University, Medical School, Department of Pediatric Surgery, 21280 Diyarbakir, Turkey. ozturkhayrettin@hotmail.com
Onen
Abdurrahman
A
Otçu
Selcuk
S
Dokucu
Ali Ihsan
AI
Gedik
Senol
S
D000305:Adrenal Cortex Hormones / Q000009:adverse effects; D000893:Anti-Inflammatory Agents / Q000009:adverse effects; D005260:Female; D006801:Humans; D007231:Infant, Newborn; D007234:Infant, Premature / Q000502:physiology; D008297:Male; D012189:Retrospective Studies; D012422:Rupture, Spontaneous; D018805:Sepsis / Q000150:complications; D013272:Stomach Diseases / Q000209:etiology* / Q000503:physiopathology*; D016896:Treatment Outcome
D000305:Adrenal Cortex Hormones; D000893:Anti-Inflammatory Agents